Abstract
Aim: Recently it was established that the deficit of Klotho morphogenetic protein in serum is one of the most likely predictors of cardiovascular mortality. Purpose of the Study: to examine the association of Klotho with adverse prognosis factors in patients with acute non-ST-segment elevation myocardial infarction and chronic kidney disease. Materials and Methods of the Study: The analysis included patients with acute myocardial infarction without ST-segment elevation and chronic kidney disease. Inclusion criteria: AMI without persistent ST-segment elevation that underwent coronary artery stenting after coronary angiography; presence of chronic kidney disease diagnosed as a decrease in glomerular filtration rate less than 60 ml/min/1.73m2. Exclusion criteria: terminal CKD or patients on program hemodialysis, presence of acute kidney injury, cancer, refusal to participate in the study. Results: Initial analysis showed that decreased Klotho levels were common among elderly patients, and among these patients there was more frequent history of myocardial revascularization, as well as a higher risk of adverse events according to the GRACE scale. The association of Klotho level with three cardiovascular complications risk factors—age (β = −9.884 (SD 1.667), p = 0.000), C-reactive protein level (β = −0.661 (SD 0.205), p = 0.002) and troponin (β = −0.07 (SD 0.031), p = 0.026)—was determined by multiple linear regression method. Conclusion: The prospective study demonstrated that Klotho may act as one of the markers of cardiovascular risk in patients with non-ST elevation myocardial infarction and chronic kidney disease. Its independent association with three risk factors of cardiovascular risk – age, C-reactive protein level and troponin was established.

This publication has 25 references indexed in Scilit: